Virtus ETF Advisers’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-57,437	Closed	-$116K	–	495
2022 Q1	$116K	Sell	57,437 -3,399	-6%	-$6.68K	0.05%	277
2021 Q4	$165K	Buy	60,836 +24,426	+67%	+$90.3K	0.06%	312
2021 Q3	$162K	Sell	36,410 -1,893	-5%	-$9.12K	0.07%	323
2021 Q2	$222K	Buy	+38,303	New	+$224K	0.09%	270
2020 Q4	–	Sell	-86,459	Closed	-$504K	–	365
2020 Q3	$504K	Buy	86,459 +7,282	+9%	+$43.6K	0.26%	135
2020 Q2	$534K	Buy	79,177 +33,423	+73%	+$253K	0.25%	145
2020 Q1	$291K	Sell	45,754 -3,861	-8%	-$31K	0.12%	225
2019 Q4	$517K	Sell	49,615 -3,890	-7%	-$28.3K	0.08%	202
2019 Q3	$210K	Sell	53,505 -9,004	-14%	-$72.8K	0.04%	239
2019 Q2	$930K	Buy	+62,509	New	+$1.13M	0.2%	151
2019 Q1	–	Sell	-30,876	Closed	-$555K	–	282
2018 Q4	$555K	Buy	30,876 +13,775	+81%	+$281K	0.09%	66
2018 Q3	$502K	Buy	17,101 +1,171	+7%	+$45.3K	0.05%	122
2018 Q2	$724K	Buy	15,930 +1,827	+13%	+$88.9K	0.64%	89
2018 Q1	$745K	Sell	14,103 -826	-6%	-$48.2K	0.65%	87
2017 Q4	$1.01M	Sell	14,929 -1,420	-9%	-$99.3K	1.27%	15
2017 Q3	$1.35M	Hold	16,349	–	–	0.18%	42
2017 Q2	$1.53M	Buy	16,349 +8,552	+110%	+$523K	0.23%	34
2017 Q1	$496K	Buy	7,797 +743	+11%	+$45.2K	0.09%	102
2016 Q4	$313K	Sell	7,054 -10,811	-61%	-$381K	0.09%	108
2016 Q3	$644K	Hold	17,865	–	–	0.31%	56
2016 Q2	$245K	Buy	17,865 +10,339	+137%	+$151K	0.18%	95
2016 Q1	$144K	Sell	7,526 -473	-6%	-$10K	0.2%	126
2015 Q4	$280K	Buy	+7,999	New	+$516K	0.77%	45

Other funds holding CLVS